炎症性肠病的机制和诊疗新策略研究；

非酒精性脂肪肝等慢性肝病发病机制和防治研究；

肠-肝对话机制研究

Basic and clinical research on Inflammatory Bowel Disease（IBD） and chronic liver diseases such as Non-alcohilic Fatty liver Disease(NAFLD)

上海市东方医院南院消化科主任

Director, Department of Gastroenterology, Southern Campus of Shanghai East Hospital

国家医学考试中心试题开发专家委员会委员

Member of Expert Committee, the National Medical Examination Center

国家医学考试中心试题开发专家委员会消化专业组副组长

Vice-chairman of group of digestive disease, expert committee of National Medical Examination Center

上海市医师协会消化分会委员

Member of the standing committee, Digestive branch of Shanghai Physicians Association

上海市医学会消化分会肝胆学组委员

Member of group of liver and biliary diseases, Shanghai Society of Gastroenterology

上海市医学会消化内镜专科分会青年委员

Young committee member  of Shanghai Society of Digestive Endoscopy

上海市医学会消化内镜专科分会大肠病学组委员

Member of group of colon diseases,  Shanghai Society of Digestive Endoscopy

上海市中西医结合学会消化分会委员

Member of the standing committee, Digestive branch of Shanghai Society of Integrated Traditional Chinese and Western medicine

上海市中西医结合学会消化分会肝病学组副组长

Deputy leader of Group of Liver Diseases, Shanghai Society of Integrated Chinese and Western medicine

上海市中西医结合学会器官纤维化专业委员会委员

Member of Organ Fibrosis Committee of Shanghai Society of Integrated Traditional Chinese and Western medicine

上海市康复医学会第一届消化康复专业委员会

Member of the first Digestive Rehabilitation Committee of Shanghai Society for Rehabilitation Medicine

主要研究领域涉及慢性肝病及肝纤维化、炎症性肠病等消化道疾病，在国内较早建立了肥胖、高脂血症性NASH的动物模型，并开展了系列研究。近年来致力于揭示炎症性肠病发病机制和肠-肝对话，解析新的治疗靶点，建立了炎症性肠病的生物样本库，创新性开展人脐带间充质干细胞治疗难治性中重度克罗恩病的单臂、开放标签的临床研究，通过clinicalTrial.gov国际临床试验注册，编号为：NCT05262829。发表SCI论文总影响因子30分以上，被授予上海市浦东新区优秀科技论文三等奖、上海市医学科技奖三等奖和上海市科学技术进步奖三等奖（第五完成人）等，主持国家自然科学基金面上项目1项（在研），上海市卫健委课题3项（在研1项）、浦东新区科委课题2项（在研1项）及浦东新区卫健委学科建设项目——炎症性肠病特色专病（在研）等。

Prof. Zhong’s main research area involves chronic liver disease, liver fibrosis, inflammatory bowel disease (IBD) and other digestive tract diseases. She established the models of obesity and hyperlipidemia Non-alcoholic steatohepatittis (NASH) in rats in China, and a series of studies were carried out by using this model. In recent years, her team have devoted to revealing the pathogenesis of inflammatory bowel disease and the gut-liver crosstalk, to analyzing new therapeutic targets, and to building up a sample bank of IBD. She also explored the safteness and effectiveness of Mesenchymal stem cell in treatment of Crohn’s Disease, the related articles have been submitted to EbioMedicine, a lancet publication.

She’s been a PI in a lot of IBD clinical trial and was awarded the third prize of excellent scientific and technological paper of Pudong New Area, the third prize of Shanghai Medical Science and Technology Award and the Third Prize of Shanghai Science and Technology Progress Award, her work was funded by General Program of National Natural Science Foundation of China, Technology Development Project of Pudong Science, Technology and Economic Commission of Shanghai, Specialty Feature Construction Project of ShanghaiPudong New Area Health Commission and the Scientific research project of Shanghai Municipal Health Committee.